Fujian Provincial Maternity and Children's Hospital, Affiliated Hospital of Fujian Medical University, Fujian Provincial Key Laboratory for Prenatal Diagnosis and Birth Defect, Fuzhou, China.
Mol Genet Genomic Med. 2019 Aug;7(8):e811. doi: 10.1002/mgg3.811. Epub 2019 Jun 17.
Submicroscopic chromosomal imbalance is associated with an increased nuchal translucency (NT). Most previous research has recommended the use of chromosomal microarray analysis (CMA) for prenatal diagnosis if the NT ≥ 3.5 mm. However, there is no current global consensus on the cutoff value for CMA. In this study, we aimed to discuss the fetuses with smaller increased NT which was between cutoff value of NT for karyotype analysis (NT of 2.5 mm in China) and the recommended cutoff value for CMA (NT of 3.5 mm) whether should be excluded from CMA test.
Singleton pregnant women (N = 192) who had undergone invasive procedures owing to an increased NT (NT ≥ 2.5 mm) were enrolled. Fetal cells were collected and subjected to single nucleotide polymorphism array and karyotype analyses simultaneously. Cases were excluded if the karyotype analysis indicated aneuploidy and apparent structural aberrations.
Fourteen cases of aneuploidy and four cases of structural abnormalities were excluded. Of the remaining 174 cases, 119 fetuses had NTs of 2.5-3.4 mm, and 55 fetuses with NT ≥ 3.5 mm. Eleven copy number variants (CNVs) were identified. In fetuses with smaller NTs, six (6/119, 5.9%) variations were detected, including two (2/119, 1.6%) clinically significant CNVs (pathogenic or likely pathogenic CNV), one likely benign CNV, two variants unknown significance, and one incidental CNV. Five (5/55, 9.1%) variations were found in fetuses with NT ≥ 3.5 mm. Among these CNVs, three (3/55, 5.5%) cases had clinically significant CNVs, and two had likely benign CNV. There were no statistically significant differences in the incidence of all CNVs and clinically significant CNVs in the two groups (p > 0.05).
CMA improved the diagnostic yield of chromosomal aberrations for fetuses with NTs of 2.5-3.4 mm and apparently normal karyotype, regardless of whether other ultrasonic abnormalities were observed.
亚微观染色体不平衡与颈项透明层(NT)增加有关。大多数先前的研究建议,如果 NT≥3.5mm,则进行染色体微阵列分析(CMA)进行产前诊断。然而,目前对于 CMA 的截止值尚无全球共识。在这项研究中,我们旨在讨论 NT 介于核型分析的截止值(中国为 2.5mm 的 NT)和推荐的 CMA 截止值(3.5mm 的 NT)之间的较小增加 NT 的胎儿是否应排除在 CMA 测试之外。
纳入了 192 名因 NT 增加(NT≥2.5mm)而接受侵入性程序的单胎孕妇。同时收集胎儿细胞并进行单核苷酸多态性微阵列和核型分析。如果核型分析显示非整倍体和明显的结构异常,则排除病例。
排除了 14 例非整倍体和 4 例结构异常。在剩余的 174 例中,119 例胎儿的 NT 为 2.5-3.4mm,55 例胎儿的 NT≥3.5mm。确定了 11 个拷贝数变异(CNV)。在 NT 较小的胎儿中,检测到 6 个(6/119,5.9%)变异,包括 2 个(2/119,1.6%)临床意义明确的 CNV(致病性或可能致病性 CNV),1 个可能良性 CNV,2 个变异意义不明,1 个偶然 CNV。在 NT≥3.5mm 的胎儿中发现 5 个(5/55,9.1%)变异。在这些 CNV 中,有 3 例(3/55,5.5%)具有临床意义明确的 CNV,有 2 例具有可能良性 CNV。两组之间所有 CNV 和临床意义明确的 CNV 的发生率均无统计学差异(p>0.05)。
对于 NT 为 2.5-3.4mm 且核型正常的胎儿,CMA 可提高染色体异常的诊断率,无论是否存在其他超声异常。